Arnaud Foussat
Chief Executive Officer at Yukin Therapeutics SAS
Profile
Arnaud Foussat is currently the Chief Executive Officer at Yukin Therapeutics SAS and the Chairman at Alderaan Biotechnology SAS.
Previously, he worked as the Principal at Institut National de la Santé & de la Recherche Médicale and as the Chief Scientific Officer & Vice President at Sangamo Therapeutics France SAS.
Dr. Foussat holds an undergraduate degree from the University of Strasbourg and a doctorate degree from Université Paris Diderot-Paris 7.
Arnaud Foussat active positions
| Companies | Position | Start |
|---|---|---|
Alderaan Biotechnology SAS
 Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Chairman | - |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Chief Executive Officer | 31/05/2018 |
Former positions of Arnaud Foussat
| Companies | Position | End |
|---|---|---|
| TXCELL | Chief Tech/Sci/R&D Officer | 28/02/2017 |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Corporate Officer/Principal | - |
Training of Arnaud Foussat
| University of Strasbourg | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
| Université Paris Diderot-Paris 7 | Consumer Services |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Health Technology |
Yukin Therapeutics SAS
Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Arnaud Foussat